STRIDES PHARMA SCIENCE
Quarterly Results Analysis [Dec2023]
STRIDES PHARMA SCIENCE Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,038 Cr | ₹999 Cr | ₹930 Cr | ₹986 Cr | ₹865 Cr | ₹897 Cr | ₹940 Cr | ₹866 Cr |
Expenses | ₹844 Cr | ₹846 Cr | ₹763 Cr | ₹831 Cr | ₹749 Cr | ₹799 Cr | ₹880 Cr | ₹824 Cr |
Operating Income | ₹194 Cr | ₹153 Cr | ₹167 Cr | ₹156 Cr | ₹116 Cr | ₹98 Cr | ₹60 Cr | ₹42 Cr |
Other Income | ₹9 Cr | ₹36 Cr | ₹9 Cr | ₹27 Cr | ₹26 Cr | ₹23 Cr | ₹14 Cr | ₹86 Cr |
Interest | ₹79 Cr | ₹79 Cr | ₹76 Cr | ₹81 Cr | ₹58 Cr | ₹68 Cr | ₹55 Cr | ₹49 Cr |
Depreciation | ₹51 Cr | ₹60 Cr | ₹60 Cr | ₹61 Cr | ₹60 Cr | ₹62 Cr | ₹60 Cr | ₹61 Cr |
Profit Before Tax | ₹62 Cr | ₹-115 Cr | ₹33 Cr | ₹34 Cr | ₹65 Cr | ₹7 Cr | ₹-107 Cr | ₹-59 Cr |
Profit After Tax | ₹52 Cr | ₹-107 Cr | ₹24 Cr | ₹27 Cr | ₹61 Cr | ₹45 Cr | ₹-79 Cr | ₹73 Cr |
EPS | ₹5.41 | ₹-14.54 | ₹-0.79 | ₹-1.06 | ₹-8.86 | ₹2.53 | ₹-15.13 | ₹3.25 |
Industry Peers & Returns | 1W | 1M | 1Y |
STRIDES PHARMA SCIENCE | 0.5% | -4.2% | 183.8% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
STRIDES PHARMA SCIENCE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 3.83 % |
Y-o-Y | 19.98 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹1,038 Cr | 3.83 | |
Sep2023 | ₹999 Cr | 7.47 | |
Jun2023 | ₹930 Cr | -5.72 | |
Mar2023 | ₹986 Cr | 14.05 | |
Dec2022 | ₹865 Cr | -3.60 | |
Sep2022 | ₹897 Cr | -4.57 | |
Jun2022 | ₹940 Cr | 8.55 | |
Mar2022 | ₹866 Cr | - |
STRIDES PHARMA SCIENCE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 26.57 % |
Y-o-Y | 66.59 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹194 Cr | 26.57 | |
Sep2023 | ₹153 Cr | -8.08 | |
Jun2023 | ₹167 Cr | 7.09 | |
Mar2023 | ₹156 Cr | 33.71 | |
Dec2022 | ₹116 Cr | 18.56 | |
Sep2022 | ₹98 Cr | 63.13 | |
Jun2022 | ₹60 Cr | 42.66 | |
Mar2022 | ₹42 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 21.93 % |
Y-o-Y | 38.88 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 18.68% | 21.93 | |
Sep2023 | 15.32% | -14.46 | |
Jun2023 | 17.91% | 13.57 | |
Mar2023 | 15.77% | 17.25 | |
Dec2022 | 13.45% | 22.94 | |
Sep2022 | 10.94% | 70.94 | |
Jun2022 | 6.4% | 31.42 | |
Mar2022 | 4.87% | - |
STRIDES PHARMA SCIENCE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -15.43 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹52 Cr | Positive | |
Sep2023 | ₹-107 Cr | Negative | |
Jun2023 | ₹24 Cr | -12.08 | |
Mar2023 | ₹27 Cr | -56.30 | |
Dec2022 | ₹61 Cr | 35.81 | |
Sep2022 | ₹45 Cr | Positive | |
Jun2022 | ₹-79 Cr | Negative | |
Mar2022 | ₹73 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -29.48 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 5 % | Positive | |
Sep2023 | -10.73 % | Negative | |
Jun2023 | 2.53 % | -6.99 | |
Mar2023 | 2.72 % | -61.64 | |
Dec2022 | 7.09 % | 40.67 | |
Sep2022 | 5.04 % | Positive | |
Jun2022 | -8.4 % | Negative | |
Mar2022 | 8.38 % | - |
STRIDES PHARMA SCIENCE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹5.41 | Positive | |
Sep2023 | ₹-14.54 | Negative | |
Jun2023 | ₹-0.79 | Negative | |
Mar2023 | ₹-1.06 | Negative | |
Dec2022 | ₹-8.86 | Negative | |
Sep2022 | ₹2.53 | Positive | |
Jun2022 | ₹-15.13 | Negative | |
Mar2022 | ₹3.25 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD